Table 4 Predictors of length of stay after lobectomy for lung cancer in both sugammadex and pyridostigmine cohorts. Variables were selected from multivariable poisson regression model using forward selection and backward elimination based on the Akaike information criterion

 Age ≥ 65 yr

1.09 (1.10–1.18)

0.021

 Male sex

1.27 (1.16–1.38)

< 0.001

 Diabetes mellitus

0.82 (0.75–0.90)

< 0.001

 COPD

1.33 (1.23–1.43)

< 0.001

 Sugammadex (vs. pyridostigmine)

0.88 (0.82–0.95)

< 0.001

 Dyspnea

1.39 (1.27–1.55)

< 0.001

 Atelectasis

1.21 (1.12–1.30)

< 0.001

 Pneumonia

1.77 (1.58–1.99)

< 0.001

 Air leak > 5 days

1.40 (1.33–1.46)

< 0.001